Aug 012017

via University of Central Florida

Attaching curcumin, a component of the common spice turmeric, to nanoparticles can be used to target and destroy treatment-resistant neuroblastoma tumor cells, according to a new study published in Nanoscale. The study, conducted in partnership by researchers at Nemours Children’s Hospital and the University of Central Florida, demonstrates a potentially novel treatment for neuroblastoma, the most common cancer in infants.

“High-risk neuroblastoma can be resistant to traditional therapy, and survival can be poor. This research demonstrates a novel method of treating this tumor without the toxicity of aggressive therapy that can also have late effects on the patient’s health,” said Tamarah J. Westmoreland, MD, PhD, a pediatric surgeon at Nemours Children’s Health System and senior author of the study. “Unique approaches to target tumor cells with nanoparticle delivery systems hold promise for treatment of resistant tumors, such as the high risk neuroblastoma. We are hopeful that in the future, nanoparticles can be utilized to personalize care to patients and reduce the late effects of therapy.”

Neuroblastomas are cancers that start in early nerve cells and commonly form in the tissue of the adrenal glands, near the kidneys. About 700 new cases of neuroblastoma are diagnosed each year in the United States and most cases appear in children younger than 5 years old. High-risk neuroblastoma is hard to cure and is more likely to become resistant to standard therapies or recur. These cancers are also associated with late effects after treatments have ended, including developmental delays, hearing loss, or other disabilities.

Curcumin has been shown to have substantial anti-cancer ability, but its low solubility and poor stability have made its use in medicinal applications challenging. Researchers from Nemours and UCF found that nanoparticles can be used to deliver curcumin to tumor sites.

“This shows that nanoparticles can be an effective delivery vehicle for cancer drugs,” said Professor Sudipta Seal, who directs of UCF’s NanoScience Technology Center and Advanced Materials Processing Analysis Center, and is a collaborator on the study. “More research is needed, but we are hopeful it could lead to more effective treatment of this devastating disease in the future.”

In the study, researchers loaded Cerium oxide nanoparticles with curcumin and coated them with dextran to test in cell lines of a high-risk form of neuroblastoma, known as MYCN-amplified, as well as non-amplified neuroblastoma. This formulation induced substantial cell death in neuroblastoma cells while producing no or only minor toxicity in healthy cells. Overall, the nano-therapeutic treatments showed a more pronounced effect in MYCN-amplified cells, which are traditionally more resistant to drug therapies.

Nanoscience research, which explores the unusual properties of materials at the nanoscale, has led to advancements in medicine, energy, information storage, computing and other fields. At no more than 100 nanometers, nanoparticles are exceedingly small. By comparison, a sheet of paper is about 75,000 nanometers thick.

This study was conducted in a laboratory setting in Orlando, at Nemours Children’s Hospital and the University of Central Florida in cells from children with neuroblastoma, but researchers hope to begin to use these curcumin nanoparticles with micro RNA in animal models to direct the molecule to a tumor site.

Learn more: UCF, Nemours Collaborate to Defeat Difficult-to-Treat Childhood Cancer


The Latest on: Neuroblastoma
  • Neuroblastoma Treatment Market Analysis by Size & Share by 2022
    on December 12, 2017 at 4:02 pm

    The neuroblastoma treatment market is mainly driven by the rising incidences of cancer worldwide. Neuroblastoma (NB) is the most common cancer in childhood and infancy. Neuroblastoma is a cancer that starts in primitive nerve cells. Sarasota, FL -- (SBWIRE ... […]

  • Children's Hospital at Erlanger to receive Brave Gowns
    on December 12, 2017 at 11:09 am

    Emily's Power for a Cure, a Chattanooga organization that raises funds to help find a cure for Neuroblastoma and support local families with children fighting the disease, is donating 600 Brave Gowns to the hospital. A statement from an Erlanger spokesman ... […]

  • LIFE STORIES: Mom comes back from homelessness after toddler's death
    on December 12, 2017 at 5:24 am

    "He had been a healthy kid, 100 percent," she said. A CT scan revealed a cancerous tumor in his bones. Jamie was diagnosed with neuroblastoma and childhood leukemia. "It was the scariest day of my life," Straube said. "When they said cancer, I fell to my ... […]

  • Hoosiers play big role in national health policy
    on December 10, 2017 at 8:43 pm

    “And a few years back, my neighbor, Aidan, was diagnosed with a stage 4 neuroblastoma. He was only 4 years old. A large tumor had been growing for some time, maybe since he was born, and it was wrapped all around his kidney. Aidan went through ... […]

  • A "Christmas Carol" with its own little miracle
    on December 10, 2017 at 5:48 am

    When Paris was only nine days old, she was diagnosed with Stage 3 Neuroblastoma, a rare and deadly form of childhood cancer. "They told us because she was so small, and because the tumor was so large, that most likely she wasn't going to make it through ... […]

  • Rudolph named Minnesota Vikings 2017 Man of the Year
    on December 8, 2017 at 10:36 am

    Kyle Rudolph’s first personal exposure to cancer came when his brother, Casey, who is 15 months younger than Kyle, was diagnosed with neuroblastoma when he was born. The trials in Casey’s first two years of life helped spawn Kyle’s interest in ... […]

  • LMK Raises Money For Neuroblastoma Research
    on December 5, 2017 at 8:05 pm

    The students and teachers of Louis M. Klein Middle School sponsored a week long fundraiser for "Band of Parents" – a non-profit organization which raises money for Neuroblastoma Research. For the LMK community, there was a personal connection to the cause. […]

  • St. Baldrick's Foundation Appoints Neuroblastoma Expert, Dr. Susan Cohn, to its Board of Directors
    on December 4, 2017 at 10:40 am

    "As a dedicated research scientist in the field of pediatric cancer, Dr. Cohn is committed to seeking and progressing advancements in the field of childhood cancer research," said Michael McCreesh, chairman of the St. Baldrick's Foundation board of directors. […]

  • What is neuroblastoma? The signs and symptoms of the cancer Bradley Lowery battled that affects babies and young children
    on December 4, 2017 at 5:31 am

    NEUROBLASTOMA is a rare form of cancer that mostly affects babies and young children. Football mascot Bradley Lowery, who captured the hearts of the nation, lost his battle against the disease earlier this year. Here's all you need to know about the ... […]

  • Alex’s Lemonade Stand funds Phase 1 neuroblastoma trial
    on December 4, 2017 at 12:00 am

    Neuroblastoma is the most common solid tumor cancer in children and is challenging to treat regardless of existing therapies that are available. Dr. Andras Heczey, assistant professor of pediatrics - hematology and oncology, and Dr. Leonid Metelitsa ... […]

via Google News and Bing News

Other Interesting Posts

Leave a Reply

%d bloggers like this: